• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Follicular lymphoma, survival, and rituximab: is it time to declare victory?

作者信息

Horning Sandra J

出版信息

J Clin Oncol. 2008 Oct 1;26(28):4537-8. doi: 10.1200/JCO.2008.16.1398. Epub 2008 Jul 28.

DOI:10.1200/JCO.2008.16.1398
PMID:18662966
Abstract
摘要

相似文献

1
Follicular lymphoma, survival, and rituximab: is it time to declare victory?滤泡性淋巴瘤、生存率与利妥昔单抗：是时候宣告胜利了吗？
J Clin Oncol. 2008 Oct 1;26(28):4537-8. doi: 10.1200/JCO.2008.16.1398. Epub 2008 Jul 28.
2
Update on front-line therapy for follicular lymphoma: chemo-immunotherapy with rituximab and survival.滤泡性淋巴瘤一线治疗的最新进展：利妥昔单抗化疗免疫疗法与生存情况
Expert Rev Anticancer Ther. 2007 Jul;7(7):959-65. doi: 10.1586/14737140.7.7.959.
3
Introduction of rituximab in front-line and salvage therapies has improved outcome of advanced-stage follicular lymphoma patients.在一线和挽救治疗中引入利妥昔单抗已改善了晚期滤泡性淋巴瘤患者的治疗结果。
Cancer. 2007 May 15;109(10):2077-82. doi: 10.1002/cncr.22649.
4
Current status of rituximab maintenance therapy.利妥昔单抗维持治疗的现状
Clin Adv Hematol Oncol. 2007 Dec;5(12):968-9,1006.
5
Optimizing rituximab in B-cell lymphoma.优化利妥昔单抗在B细胞淋巴瘤中的应用。
J Clin Oncol. 2005 Feb 20;23(6):1056-8. doi: 10.1200/JCO.2005.09.924. Epub 2005 Jan 18.
6
Re: Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials.
J Natl Cancer Inst. 2009 Sep 16;101(18):1287-8; author reply 1289-90. doi: 10.1093/jnci/djp255. Epub 2009 Aug 17.
7
Factors predictive for response of follicular and mantle-cell lymphoma to rituximab.滤泡性和套细胞淋巴瘤对利妥昔单抗反应的预测因素。
Nat Clin Pract Oncol. 2006 Apr;3(4):184-5. doi: 10.1038/ncponc0457.
8
Rituximab: new indication. Lymphoma maintenance therapy: inadequate follow-up.
Prescrire Int. 2007 Oct;16(91):189.
9
[New data prove therapeutic superiority. MabThera in follicular and mantle cell lymphoma].[新数据证明治疗优势。美罗华用于滤泡性和套细胞淋巴瘤]
Krankenpfl J. 2002;40(5-6):161.
10
[Rituximab (antiCD20 monoclonal antibody) and molecular-biological negativity in the treatment of patients with follicular lymphoma--a way to a cure?--Editorial].
Vnitr Lek. 2007 Oct;53(10):1029-30.

引用本文的文献

1
Analysis and prediction of relative survival trends in patients with non-Hodgkin lymphoma in the United States using a model-based period analysis method.使用基于模型的时期分析方法对美国非霍奇金淋巴瘤患者的相对生存趋势进行分析和预测。
Front Oncol. 2022 Sep 27;12:942122. doi: 10.3389/fonc.2022.942122. eCollection 2022.
2
Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality Trends.非霍奇金淋巴瘤亚型对死亡率趋势的影响
Cancer Epidemiol Biomarkers Prev. 2016 Jan;25(1):174-9. doi: 10.1158/1055-9965.EPI-15-0921. Epub 2015 Oct 15.
3
Modulation of deoxycytidine kinase (dCK) and glycogen synthase kinase (GSK-3β) by anti-CD20 (rituximab) and 2-chlorodeoxyadenosine (2-CdA) in human lymphoid malignancies.
抗 CD20（利妥昔单抗）和 2-氯脱氧腺苷（2-CdA）对人淋巴系统恶性肿瘤脱氧胞苷激酶（dCK）和糖原合酶激酶（GSK-3β）的调节作用。
Exp Hematol Oncol. 2014 Dec 19;3:31. doi: 10.1186/2162-3619-3-31. eCollection 2014.
4
Randomized phase II study of concurrent and sequential combinations of rituximab plus CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) chemotherapy in untreated indolent B-cell non-Hodgkin lymphoma: 7-year follow-up results.随机对照 II 期研究：利妥昔单抗联合 CHOP（环磷酰胺、多柔比星、长春新碱和泼尼松）化疗治疗未经治疗的惰性 B 细胞非霍奇金淋巴瘤：7 年随访结果。
Cancer Sci. 2010 Dec;101(12):2579-85. doi: 10.1111/j.1349-7006.2010.01703.x.
5
Rituximab: a review of its use in chronic lymphocytic leukaemia, low-grade or follicular lymphoma and diffuse large B-cell lymphoma.利妥昔单抗：在慢性淋巴细胞白血病、低级别或滤泡性淋巴瘤以及弥漫性大 B 细胞淋巴瘤中的应用综述。
Drugs. 2010 Jul 30;70(11):1445-76. doi: 10.2165/11201110-000000000-00000.
6
Impact of Rituximab (Rituxan) on the Treatment of B-Cell Non-Hodgkin's Lymphoma.利妥昔单抗（美罗华）对B细胞非霍奇金淋巴瘤治疗的影响。
P T. 2010 Mar;35(3):148-57.
7
Rituximab for the treatment of non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.利妥昔单抗治疗非霍奇金淋巴瘤和慢性淋巴细胞白血病。
Drugs. 2010 Feb 12;70(3):261-72. doi: 10.2165/11532180-000000000-00000.
8
A Case of Chronic Conjunctivitis following Rituximab Therapy.利妥昔单抗治疗后发生慢性结膜炎1例。
Adv Hematol. 2009;2009:272495. doi: 10.1155/2009/272495. Epub 2009 Sep 1.